​

CME Group (CME) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CME Stock Forecast

CME Group stock forecast is as follows: an average price target of $224.14 (represents a -6.03% downside from CME’s last price of $238.53) and a rating consensus of 'Hold', based on 15 wall street analysts offering a 1-year stock forecast.

CME Price Target

The average price target for CME Group (CME) is $224.14 based on 1-year price targets from 15 Wall Street analysts in the past 3 months, with a price target range of $258.00 to $177.00. This represents a potential -6.03% downside from CME's last price of $238.53.

CME Analyst Ratings

Hold

According to 15 Wall Street analysts, CME Group's rating consensus is 'Hold'. The analyst rating breakdown for CME stock is 0 'Strong Buy' (0.00%), 5 'Buy' (33.33%), 8 'Hold' (53.33%), 2 'Sell' (13.33%), and 0 'Strong Sell' (0.00%).

CME Group Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 24, 2024Owen LauOppenheimer$258.00$227.4313.44%8.16%
Oct 24, 2024Benjamin BudishBarclays$231.00$227.141.70%-3.16%
Oct 03, 2024Christopher AllenCitigroup$250.00$223.5711.82%4.81%
Sep 26, 2024Ashish SabadraRBC Capital$235.00$218.477.57%-1.48%
Sep 03, 2024Craig SiegenthalerBank of America Securities$177.00$215.74-17.96%-25.80%
Jul 25, 2024Brian BedellDeutsche Bank$193.00$198.92-2.98%-19.09%
Jul 25, 2024Patrick MoleyPiper Sandler$225.00$199.3812.85%-5.67%
Jul 25, 2024Benjamin BudishBarclays$209.00$197.255.96%-12.38%
Jun 05, 2024Alex KrommUBS$250.00$203.7822.68%4.81%
Apr 25, 2024Andrew BondRosenblatt Securities$187.00$212.59-12.04%-21.60%
Apr 25, 2024Benjamin BudishBarclays$228.00$212.597.25%-4.41%
Apr 05, 2024Brian BedellDeutsche Bank$210.00$212.21-1.04%-11.96%
Feb 07, 2023Credit Suisse$198.00$174.7613.30%-16.99%
Jan 11, 2023Morgan Stanley$196.00$176.9310.78%-17.83%
Dec 19, 2022Piper Sandler$250.00$171.1246.10%4.81%
Sep 06, 2022Credit Suisse$210.00$194.697.86%-11.96%
Aug 17, 2022Rosenblatt Securities$171.00$205.46-16.77%-28.31%
Aug 12, 2022Deutsche Bank$212.00$202.154.88%-11.12%
Aug 03, 2022Credit Suisse$216.00$198.258.96%-9.45%
Aug 02, 2022UBS$240.00$195.3422.86%0.62%
Jul 28, 2022Morgan Stanley$226.00$198.5013.85%-5.25%
Jul 28, 2022Credit Suisse$218.00$195.9911.23%-8.61%
Jul 19, 2022Morgan Stanley$242.00$201.5120.09%1.45%
Jul 13, 2022Deutsche Bank$213.00$203.554.64%-10.70%
Jul 06, 2022Credit Suisse$233.00$204.3614.01%-2.32%
Jul 06, 2022UBS$246.00$204.3620.38%3.13%
Jul 06, 2022Raymond James$235.00$204.3614.99%-1.48%
Jun 10, 2022Simon ClinchAtlantic Equities$235.00$200.4317.25%-1.48%
Jun 03, 2022UBS$258.00$204.6826.05%8.16%
May 19, 2022Deutsche Bank$210.00$190.1510.44%-11.96%
May 16, 2022Stephen BiggarArgus Research$230.00$200.1014.94%-3.58%
Apr 28, 2022Citigroup$280.00$223.0025.56%17.39%
Apr 28, 2022Credit Suisse$259.00$223.0316.13%8.58%
Apr 28, 2022Raymond James$254.00$225.9312.42%6.49%
Apr 05, 2022Alex KrommUBS$269.00$237.4613.28%12.77%
Jan 10, 2022Daniel FannonJefferies$258.00$221.8016.32%8.16%
Nov 02, 2021Eoin MullanyBerenberg Bank$190.00$215.65-11.89%-20.35%
Oct 01, 2021Richard RepettoPiper Sandler$230.00$192.1819.68%-3.58%
Apr 29, 2021Kenneth HillLoop Capital Markets$151.00$197.42-23.51%-36.70%
Apr 28, 2021Alexander BlosteinGoldman Sachs$208.00$194.796.78%-12.80%

The latest CME Group stock forecast, released on Oct 24, 2024 by Owen Lau from Oppenheimer, set a price target of $258.00, which represents a 13.44% increase from the stock price at the time of the forecast ($227.43), and a 8.16% increase from CME last price ($238.53).

CME Group Price Target by Period

1M3M12M
# Anlaysts-412
Avg Price Target-$243.50$221.08
Last Closing Price$238.53$238.53$238.53
Upside/Downside-100.00%2.08%-7.32%

In the current month, the average price target of CME Group stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to CME Group's last price of $238.53. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Oct 24, 2024CitigroupBuyBuyHold
Oct 17, 2024Morgan StanleyEqual-WeightEqual-WeightHold
Oct 14, 2024OppenheimerOutperformOutperformHold
Oct 08, 2024Piper SandlerOverweightOverweightHold
Oct 07, 2024BarclaysEqual-WeightEqual-WeightHold
Oct 03, 2024Goldman SachsSellSellHold
Oct 03, 2024CitigroupBuyBuyHold
Sep 26, 2024RBC CapitalSector PerformInitialise
Sep 25, 2024Cowen & Co.HoldInitialise
Sep 05, 2024CitigroupBuyBuyHold
Sep 03, 2024Bank of America SecuritiesNeutralUnderperformDowngrade
Aug 15, 2024Sandler O'NeillMarket PerformMarket PerformHold
Aug 15, 2024Sandler O'NeilUnderperformUnderperformHold
Jul 25, 2024Deutsche BankHoldHoldHold
Jul 25, 2024Sandler O'NeillMarket PerformMarket PerformHold
Jul 25, 2024Sandler O'NeilUnderperformUnderperformHold
Jul 25, 2024Piper SandlerOverweightOverweightHold
Jul 25, 2024BarclaysEqual-WeightEqual-WeightHold
Jul 09, 2024Keefe, Bruyette & WoodsUnderperformUnderperformHold
Jul 09, 2024Piper SandlerMarket PerformMarket PerformHold
Jun 21, 2024Keefe Bruyette & WoodsUnderperformUnderperformHold
Jun 21, 2024Keefe, Bruyette & WoodsMarket PerformMarket PerformHold
Jun 13, 2024CitigroupBuyBuyHold
Jun 05, 2024UBSBuyBuyHold
Apr 25, 2024Morgan StanleyMarket PerformMarket PerformHold
Apr 25, 2024Keefe, Bruyette & WoodsUnderperformUnderperformHold
Apr 25, 2024BarclaysEqual-WeightEqual-WeightHold
Apr 05, 2024Deutsche BankBuyHoldDowngrade
Apr 03, 2024BarclaysUnderperformUnderperformHold
Apr 03, 2024Keefe, Bruyette & WoodsMarket PerformMarket PerformHold
Apr 02, 2024Bank of America SecuritiesNeutralNeutralHold
Mar 06, 2024Goldman SachsBuyBuyHold
Feb 15, 2024Goldman SachsEqual-WeightEqual-WeightHold
Feb 15, 2024BarclaysUnderperformUnderperformHold
Jan 08, 2024BarclaysSellEqual-WeightDowngrade
Oct 26, 2023BarclaysSellSellHold
Oct 26, 2023Morgan StanleyEqual-WeightEqual-WeightHold
Oct 12, 2023CitigroupBuyBuyHold
Oct 11, 2023Deutsche BankBuyBuyHold
Sep 06, 2023JefferiesHoldNeutralUpgrade
Sep 06, 2023Bank of America SecuritiesNeutralUpgrade
Jul 06, 2023Raymond JamesSellSellHold
Feb 07, 2023Credit SuisseOutperformOutperformHold
Jan 11, 2023Morgan StanleyEqual-WeightEqual-WeightHold
Jan 05, 2023Credit SuisseNeutralOutperformUpgrade
Dec 19, 2022Piper SandlerOverweightOverweightHold
Oct 12, 2022JefferiesHoldDowngrade
Oct 12, 2022BTIGNeutralDowngrade
Oct 12, 2022Deutsche BankHoldBuyUpgrade
Sep 06, 2022Credit SuisseNeutralNeutralHold
Aug 15, 2022Raymond JamesOutperformMarket PerformDowngrade
Aug 12, 2022Deutsche BankHoldHoldHold
Aug 02, 2022UBSBuyBuyHold
Jul 28, 2022Credit SuisseNeutralNeutralHold
Jul 19, 2022Morgan StanleyEqual-WeightEqual-WeightHold
Jul 13, 2022Deutsche BankHoldHoldHold
Jul 06, 2022Credit SuisseNeutralNeutralHold
Jul 06, 2022UBSBuyBuyHold
Jul 06, 2022Raymond JamesOutperformOutperformHold
Jun 03, 2022UBSBuyBuyHold
May 25, 2022OppenheimerOutperformUpgrade
May 19, 2022Deutsche BankHoldHoldHold
Apr 28, 2022CitigroupBuyBuyHold
Apr 28, 2022Credit SuisseNeutralNeutralHold
Apr 28, 2022Raymond JamesOutperformOutperformHold
Apr 05, 2022UBSBuyBuyHold

CME Group's last stock rating was published by Citigroup on Oct 24, 2024. The company gave CME a "Buy" rating, the same as its previous rate.

CME Group Financial Forecast

CME Group Revenue Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
Revenue----------------$1.44B$1.34B$1.36B$1.44B$1.21B$1.23B$1.24B$1.35B$1.15B$1.11B$1.18B$1.25B$1.10B$1.08B
Avg Forecast$1.70B$1.71B$1.70B$1.67B$1.66B$1.67B$1.63B$1.62B$1.58B$1.60B$1.56B$1.54B$1.53B$1.59B$1.53B$1.48B$1.43B$1.34B$1.34B$1.41B$1.21B$1.22B$1.25B$1.33B$1.17B$1.15B$1.17B$1.26B$1.10B$1.09B
High Forecast$1.76B$1.78B$1.77B$1.73B$1.72B$1.74B$1.69B$1.69B$1.64B$1.67B$1.62B$1.58B$1.58B$1.64B$1.53B$1.48B$1.44B$1.36B$1.39B$1.47B$1.26B$1.22B$1.25B$1.33B$1.17B$1.15B$1.17B$1.26B$1.10B$1.09B
Low Forecast$1.62B$1.63B$1.62B$1.59B$1.58B$1.60B$1.56B$1.55B$1.51B$1.53B$1.49B$1.51B$1.49B$1.53B$1.53B$1.48B$1.41B$1.33B$1.28B$1.35B$1.16B$1.22B$1.25B$1.33B$1.17B$1.15B$1.17B$1.26B$1.10B$1.09B
# Analysts63333345452794548115954475510757
Surprise %----------------1.01%1.00%1.01%1.02%1.00%1.01%0.99%1.02%0.98%0.97%1.01%0.99%1.00%0.99%

CME Group's average Quarter revenue forecast for Mar 24 based on 4 analysts is $1.48B, with a low forecast of $1.48B, and a high forecast of $1.48B. CME's average Quarter revenue forecast represents a 2.56% increase compared to the company's last Quarter revenue of $1.44B (Dec 23).

CME Group EBITDA Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts63333345452794548115954475510757
EBITDA----------------$949.50M$-170.30M$-422.30M$1.00B$745.70M$828.80M$839.80M$951.00M$867.90M$1.09B$801.90M$861.10M$666.10M$672.60M
Avg Forecast$1.11B$1.12B$1.11B$1.09B$1.08B$1.10B$1.07B$1.06B$1.03B$1.05B$1.02B$1.00B$1.00B$1.04B$1.00B$1.20B$934.81M$878.16M$877.34M$1.09B$1.02B$741.92M$756.86M$992.91M$710.13M$695.91M$712.55M$871.22M$667.79M$664.75M
High Forecast$1.15B$1.16B$1.16B$1.13B$1.13B$1.14B$1.11B$1.10B$1.07B$1.09B$1.06B$1.04B$1.03B$1.08B$1.00B$1.44B$941.35M$886.95M$911.50M$1.31B$1.22B$741.92M$756.86M$1.19B$710.13M$695.91M$712.55M$1.05B$667.79M$664.75M
Low Forecast$1.06B$1.07B$1.06B$1.04B$1.04B$1.05B$1.02B$1.01B$987.84M$1.00B$973.85M$985.40M$975.65M$1.00B$1.00B$961.14M$921.74M$869.15M$838.26M$873.76M$813.37M$741.92M$756.86M$794.33M$710.13M$695.91M$712.55M$696.98M$667.79M$664.75M
Surprise %----------------1.02%-0.19%-0.48%0.92%0.73%1.12%1.11%0.96%1.22%1.56%1.13%0.99%1.00%1.01%

4 analysts predict CME's average Quarter EBITDA for Mar 24 to be $1.20B, with a high of $1.44B and a low of $961.14M. This is 26.53% upper than CME Group's previous annual EBITDA (Dec 23) of $949.50M.

CME Group Net Income Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts63333345452794548115954475510757
Net Income----------------$804.30M$750.20M$777.60M$883.80M$637.90M$679.60M$662.50M$711.00M$625.20M$926.50M$510.30M$574.40M$424.00M$411.70M
Avg Forecast$1.05B$1.07B$1.08B$1.05B$945.94M$977.59M$965.04M$961.98M$911.30M$954.61M$928.46M$921.19M$892.24M$954.79M$911.93M$812.99M$821.71M$800.16M$792.32M$739.08M$679.33M$697.88M$696.14M$671.89M$590.18M$558.34M$578.39M$561.27M$490.94M$507.43M
High Forecast$1.10B$1.12B$1.14B$1.10B$993.83M$1.03B$1.01B$1.01B$957.44M$1.00B$975.46M$956.89M$938.82M$997.85M$911.98M$975.59M$843.43M$818.18M$832.43M$886.90M$815.20M$697.88M$696.14M$806.27M$590.18M$558.34M$578.39M$673.53M$490.94M$507.43M
Low Forecast$990.31M$1.01B$1.02B$986.92M$891.18M$920.99M$909.17M$906.29M$858.54M$899.34M$874.70M$899.77M$852.82M$911.72M$911.89M$650.39M$807.23M$785.74M$746.45M$591.27M$543.47M$697.88M$696.14M$537.52M$590.18M$558.34M$578.39M$449.02M$490.94M$507.43M
Surprise %----------------0.98%0.94%0.98%1.20%0.94%0.97%0.95%1.06%1.06%1.66%0.88%1.02%0.86%0.81%

CME Group's average Quarter net income forecast for Mar 24 is $812.99M, with a range of $650.39M to $975.59M. CME's average Quarter net income forecast represents a 1.08% increase compared to the company's last Quarter net income of $804.30M (Dec 23).

CME Group SG&A Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts63333345452794548115954475510757
SG&A-----------------$32.20M$37.80M$38.30M$38.50M$35.10M$32.00M$31.80M$138.50M$152.10M$140.30M$150.30M$161.50M$154.20M
Avg Forecast$54.49M$54.87M$54.58M$53.46M$53.22M$53.73M$52.36M$52.08M$50.72M$51.46M$50.00M$49.29M$49.15M$51.01M$49.23M$181.35M$45.86M$43.08M$43.04M$164.86M$150.49M$39.21M$40.00M$149.88M$37.53M$36.78M$37.66M$146.86M$35.29M$35.13M
High Forecast$56.61M$57.01M$56.71M$55.54M$55.29M$55.82M$54.40M$54.11M$52.70M$53.46M$51.95M$50.87M$50.76M$52.80M$49.23M$217.62M$46.18M$43.51M$44.72M$197.84M$180.59M$39.21M$40.00M$179.85M$37.53M$36.78M$37.66M$176.24M$35.29M$35.13M
Low Forecast$52.06M$52.43M$52.15M$51.08M$50.85M$51.34M$50.03M$49.76M$48.46M$49.17M$47.78M$48.34M$47.86M$49.22M$49.23M$145.08M$45.22M$42.64M$41.12M$131.89M$120.39M$39.21M$40.00M$119.90M$37.53M$36.78M$37.66M$117.49M$35.29M$35.13M
Surprise %-----------------0.75%0.88%0.23%0.26%0.90%0.80%0.21%3.69%4.14%3.73%1.02%4.58%4.39%

CME Group's average Quarter SG&A projection for Dec 23 is $45.86M, based on 8 Wall Street analysts, with a range of $45.22M to $46.18M. The forecast indicates a 42.42% rise compared to CME last annual SG&A of $32.20M (Sep 23).

CME Group EPS Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts63333345452794548115954475510757
EPS----------------$2.24$2.06$2.14$2.46$1.76$1.87$1.82$1.96$1.74$2.59$1.42$1.60$1.18$1.15
Avg Forecast$2.92$2.97$3.01$2.91$2.63$2.72$2.68$2.67$2.53$2.65$2.58$2.56$2.48$2.65$2.53$2.45$2.28$2.22$2.20$2.37$1.88$1.94$1.93$2.00$1.64$1.55$1.61$1.76$1.36$1.41
High Forecast$3.07$3.12$3.16$3.06$2.76$2.85$2.82$2.81$2.66$2.79$2.71$2.66$2.61$2.77$2.53$2.45$2.34$2.27$2.31$2.50$1.92$1.94$1.93$2.00$1.64$1.55$1.61$1.76$1.36$1.41
Low Forecast$2.75$2.80$2.84$2.74$2.48$2.56$2.53$2.52$2.38$2.50$2.43$2.50$2.37$2.53$2.53$2.45$2.24$2.18$2.07$2.24$1.85$1.94$1.93$2.00$1.64$1.55$1.61$1.76$1.36$1.41
Surprise %----------------0.98%0.93%0.97%1.04%0.94%0.96%0.94%0.98%1.06%1.67%0.88%0.91%0.86%0.82%

According to 4 Wall Street analysts, CME Group's projected average Quarter EPS for Mar 24 is $2.45, with a low estimate of $2.45 and a high estimate of $2.45. This represents a 9.43% increase compared to CME previous annual EPS of $2.24 (Dec 23).

CME Group Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
ICEIntercontinental Exchange$152.79$181.7518.95%Buy
SPGIS&P Global$500.51$560.6712.02%Buy
MCOMoody's$485.63$502.003.37%Buy
MSCIMSCI$611.50$622.331.77%Buy
NDAQNasdaq$79.61$78.60-1.27%Buy
MORNMorningstar$349.69$340.00-2.77%Buy
CMECME Group$235.99$224.14-5.02%Hold

CME Forecast FAQ

Is CME Group a good buy?

No, according to 15 Wall Street analysts, CME Group (CME) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 5 'Buy' recommendations, accounting for 33.33% of CME's total ratings.

What is CME's price target?

CME Group (CME) average price target is $224.14 with a range of $177 to $258, implying a -6.03% from its last price of $238.53. The data is based on 15 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will CME Group stock go up soon?

According to Wall Street analysts' prediction for CME stock, the company can go down by -6.03% (from the last price of $238.53 to the average price target of $224.14), up by 8.16% based on the highest stock price target, and down by -25.80% based on the lowest stock price target.

Can CME Group stock reach $400?

CME's average twelve months analyst stock price target of $224.14 does not support the claim that CME Group can reach $400 in the near future.

What are CME Group's analysts' financial forecasts?

CME Group's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $6.58B (high $6.84B, low $6.29B), average EBITDA is $4.31B (high $4.48B, low $4.12B), average net income is $3.85B (high $4.05B, low $3.63B), average SG&A $211.39M (high $219.63M, low $201.98M), and average EPS is $10.7 (high $11.24, low $10.08). CME's analysts financial forecasts for the fiscal year (Dec 2027) are as follows: average revenue is $6.77B (high $7.03B, low $6.47B), average EBITDA is $4.43B (high $4.6B, low $4.23B), average net income is $4.25B (high $4.47B, low $4.01B), average SG&A $217.4M (high $225.87M, low $207.72M), and average EPS is $11.81 (high $12.41, low $11.13).

Did the CME's actual financial results beat the analysts' financial forecasts?

Based on CME Group's last annual report (Dec 2023), the company's revenue was $5.58B, beating the average analysts forecast of $5.52B by 1.02%. Apple's EBITDA was $3.79B, beating the average prediction of $3.78B by 0.15%. The company's net income was $3.19B, beating the average estimation of $3.15B by 1.03%. Apple's SG&A was $144.4M, missing the average forecast of $296.85M by -51.36%. Lastly, the company's EPS was $8.86, missing the average prediction of $9.08 by -2.43%. In terms of the last quarterly report (Dec 2023), CME Group's revenue was $1.44B, beating the average analysts' forecast of $1.43B by 0.77%. The company's EBITDA was $949.5M, beating the average prediction of $934.81M by 1.57%. CME Group's net income was $804.3M, missing the average estimation of $821.71M by -2.12%. The company's SG&A was $0, missing the average forecast of $45.86M by -100.00%. Lastly, the company's EPS was $2.24, missing the average prediction of $2.28 by -1.87%